Oxycodone OxyContin
Recent reports of inappropriate use and diversion of OxyContin tablets have prompted Purdue Pharma to include a "Black Box Warning"in the product labeling to call attention to the potential for abuse and to reinforce the FDA-approved indication "...for the management of moderate to severe pain when a continuous, around-the-clock analgesic is needed for an extended period of time..."...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Oxycodone OxyContin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1113
Article Code: 1113b
Date: September 17, 2001
Volume: 43
Pages: 80-81
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1113
Article Code: 1113b
Date: September 17, 2001
Volume: 43
Pages: 80-81
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)